Results 71 to 80 of about 59,240 (301)
Medical cannabis ‒ the Canadian perspective [PDF]
Gordon D Ko,1,2 Sara L Bober,1 Sean Mindra,3 Jason M Moreau1 1Apollo Applied Research Inc., 2Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, 3University of Ottawa Medical School, Ottawa, ON, Canada Abstract:
Mindra S, Bober SL, Ko GD, Moreau JM
core
Abstract Objective Lennox–Gastaut syndrome (LGS) is a drug‐resistant developmental and epileptic encephalopathy (DEE). Preclinical drug development for LGS is constrained by a lack of syndrome‐relevant animal models. We aimed to evaluate a Gabrb3+/D120N knock‐in (KI) mouse model of LGS by quantifying atypical absence seizures and epileptic spasms and ...
Thomas Harman +5 more
wiley +1 more source
Abstract Objective Diagnostic and treatment delays in infantile epileptic spasms syndrome (IESS) increase the risk of poor neurodevelopmental outcomes. Early clinical recognition of IESS is essential, especially in regions lacking expedited access to electroencephalograms (EEG).
Christine L. Shrock +11 more
wiley +1 more source
Medical Patients’ Awareness, Perspectives, and Experiences with Contaminated Cannabis
Introduction: Concerns about contamination in medical cannabis products have garnered media attention, but there is limited evidence in the literature documenting patient and consumer experiences.
Gabriel Spandau +5 more
doaj +1 more source
Irish Pain Society backs use of medical cannabis. [PDF]
The HPRA report recommended against the use of medical cannabis for the treatment of chronic pain.....
Leogue, Joe
core
Cannabis and Pain: A Clinical Review [PDF]
Introduction: Cannabis has been used for medical purposes across the world for centuries. As states and countries implement medical and recreational cannabis policies, increasing numbers of people are using cannabis pharmacotherapy for pain.
Hill, Kevin +3 more
core +1 more source
ABSTRACT As an increasing number of states legalize recreational cannabis, it is increasingly important to understand the optimal tax design for recreational cannabis. Currently, various tax bases (weight, potency, price) and rates are used. However, the empirical evidence on the impact of tax‐related attributes (pre‐tax prices, tetrahydrocannabinol ...
Yanyun He +4 more
wiley +1 more source
Medical Cannabis for the Primary Care Physician
Medical cannabis use is common in the United States and increasingly more socially acceptable. As more patients seek out and acquire medical cannabis, primary care physicians will be faced with a growing number of patients seeking information on the ...
Deepika Slawek +5 more
doaj +1 more source
Prueba de evaluación agronómica de tres variedades de Cannabis SP. en subregión caribe seco, Campeche (Atlántico). [PDF]
El presente informe tiene como actor principal la prueba de evaluación agronómica (PEA), en el departamento del Atlántico, Colombia. En dónde se entiende u se realiza la caracterización agronómica de 3 cultivares de cannabis sativa, provenientes de la ...
Yela Correa, Héctor Fabián
core
Research progress on the role of inflammatory mediators in the pathogenesis of epilepsy
In the central nervous system, activated immune cells lead to the overproduction of inflammatory mediators through the corresponding signal pathway. Under the stimulation of inflammatory factors, neuroinflammation ultimately occurs. Overexpression of inflammatory mediators and activated immunocytes plays an important role in the emergence and ...
Yue Yu, Fei‐Ji Sun
wiley +1 more source

